Search alternatives:
significantly related » significantly correlated (Expand Search), significantly elevated (Expand Search), significantly reduced (Expand Search)
significantly larger » significantly lower (Expand Search), significantly smaller (Expand Search), significantly higher (Expand Search)
related decrease » reported decrease (Expand Search), related disease (Expand Search), greater decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
significantly related » significantly correlated (Expand Search), significantly elevated (Expand Search), significantly reduced (Expand Search)
significantly larger » significantly lower (Expand Search), significantly smaller (Expand Search), significantly higher (Expand Search)
related decrease » reported decrease (Expand Search), related disease (Expand Search), greater decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
-
1
-
2
-
3
-
4
Study-related adverse events.
Published 2025“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
5
-
6
-
7
-
8
-
9
Study flow chart.
Published 2025“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
10
Study CONSORT diagram.
Published 2025“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
11
Average stability values (mean ± standard deviation) and statistical results.
Published 2024Subjects: -
12
-
13
Individual stability values for different gait events under various conditions.
Published 2024Subjects: -
14
-
15
-
16
-
17
-
18
Age-specific burden of IHD attributable to HSBP for males and females in 2021.
Published 2025Subjects: -
19
-
20